SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Housecall Medical (HSCL)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scott who wrote (10)2/6/1997 12:52:00 PM
From: Risberg   of 31
 
We may have a winner here. HSCL reports earnings before the market opens Feb. 10. I have been in frequent contact with Debbie Gilbert, HSCL's investor relations person, and she has reiterated that HSCL is comfortable with 0.07/share. With the following quarterly estimates at 0.15, HSCL could break out soon -- it's head is out of Wall Street's doghouse, and hopefully the carcass will follow soon. If HSCL executes on Monday and the following quarter, the stock should be up at least 50%, IMO. If HSCL earns 0.15 in the following quarter, that annualized 0.60/share should command a pe multiple of at least 20 (still under the industry average) and the stock could be at 12. Even at a pe of 15, we could hit 9. Because this company's previous growth has been an acquisition stock-swap story, an increase in the stock price will facilitate more such acquisitions and further increases in earnings. I think home care is here to stay and will continue to grow. Anyone else still care about this stock? I'm long with a big position. My advice is BUY NOW!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News